Delivery Order SPE2DB22D2006-SPE2DB25FV8CE

Award Date 2/3/25
Potential Completion Date 2/4/25
Potential Value $41K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $51,993.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product, and has a performance period through January 8, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This federal contract award, valued at $5,831.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of May 17, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $50,941.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of April 30, 2024 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, valued at $2,755.18, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 30S, a pharmaceutical product, with an ultimate completion date of November 19, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite...
This federal contract award, valued at $22,963.17, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract covers the delivery of 4566584620 ! MYRBETRIQ ER 50 MG TABLET 90S, a specialty medication. The award has a firm fixed price and an ultimate completion date of December 3, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was not designated with a set-aside...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $12,440.35 to AmerisourceBergen Drug Corp for the supply of MYRBETRIQ ER 25 MG TABLET 90S. This contract has an ultimate completion date of December 10, 2024. AmerisourceBergen is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly to military treatment facilities, veterans'...
This federal contract award, valued at $25,440.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a medical product, with a completion date of December 28, 2022. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,794.90, is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. The contract has a completion date of December 13, 2023 and is a Firm Fixed Price Delivery Order. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a...
This federal contract award, valued at $2,317.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MYRBETRIQ ER 50 MG TABLET 90S, a prescription medication. This is a firm fixed-price delivery order contract with an ultimate completion date of May 9, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award, valued at $19,113.67, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of January 8, 2025. The contract is for the supply of MYRBETRIQ ER 50 MG TABLET 90S, a pharmaceutical product. This contract is not associated with a set-aside designation, indicating open...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FV8CE
    Delivery Order

This federal contract award, valued at $40,522.22, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MYRBETRIQ ER 25 MG TABLET 90S, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of February 4, 2025 and is a Firm Fixed Price Delivery Order. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, including the DLA. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/5/25, 9:58 AM